News

    Red Glead Discovery welcomes new Director for Drug Discovery

    Mar 13, 2024

    Red Glead Discovery is happy to announce the appointment of Malene Bertelsen as Director for Drug Discovery, leading the cross-functional drug discovery department. Malene has extensive pharmaceutical industry experience from management as well as from project leadership and scientist...

    Read More

    New MSc thesis projects initated

    Feb 12, 2024

    We are excited to announce that two new MSc thesis projects have been initiated at Red Glead Discovery in collaboration with The Faculty of Engineering at Lund University. Elin Palm, working alongside Hanna Andersson, will be exploring a novel synthesis of...

    Read More

    Red Glead Discovery hosted the 4th Öresund Peptide Symposium on the 10th of October 2023

    Nov 1, 2023

    Over 100 people registered to Öresund Peptide Symposium to learn about the latest developments within peptide science. We were very excited to welcome several experts from the field to speak at the symposium, including Alesia Tietze from the University...

    Read More

    Red Glead Discovery, together with ShareLab is hosting a seminar at Oslo Science Park

    Nov 1, 2023

    Together with ShareLab, Oslo, Red Glead Discovery is organizing a Half-Day Seminar with Breakfast and a Competition: “Transforming research results into a drug development company” At this seminar we will dive into inspiring case studies of turning academic research...

    Read More

    Annual Company Day Theme: Inner Development Goals

    Sep 25, 2023

    How can we harness our inner human potential to effectively address the growing complexity of our environment and the global challenges that impact our business?     This was the theme at our annual company day, where Sarah Emond (Director,...

    Read More

    Red Glead is exhibiting at Discovery on Target in Boston, US

    Sep 22, 2023

      Red Glead is exhibiting at Discovery on Target (DOT) Boston, 25-28th of September (booth #201). The event covers advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutics....

    Read More

    Red Glead Discovery signs a new agreement for continued expansion at Medicon Village

    Sep 4, 2023

    Red Glead Discovery AB, which recently received Lund municipality’s Business Award for 2023, has signed an agreement with Medicon Village that ensures possibilities for continued expansion over the next 10 years. “The agreement is an important step in our...

    Read More

    Red Glead Discovery is hosting Öresund Peptide Symposium

    Jul 3, 2023

    Facilitating knowledge exchange and networking for experts in peptide science The Öresund Peptide Symposium is held for the fourth time since its start. The program for this year will bring together industry leaders and researchers within peptide drug discovery and green peptide...

    Read More

    Red Glead Discovery receives Lund municipality’s business award 2023

    Apr 14, 2023

    The award is given annually to a company in Lund that is working with global challenges of the future, that is innovative and that is recognised as a good ambassador for the municipality.   “We are incredibly grateful for...

    Read More

    Aqilion secures strategic research alliance with Merck worth up to EUR 950 million for their TAK1 kinase inhibitor program

    Feb 23, 2023

    We are delighted to share the news of the recent success of Aqilion, who secured an exclusive license and strategic research collaboration with Merck. The deal is worth up to EUR 950 million for their pre-clinical TAK1 inhibitor program....

    Read More